Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Debt Ratio: 2024-2025

Historic Debt Ratio for Apellis Pharmaceuticals (APLS) over the last 2 years, with Sep 2025 value amounting to 0.43.

  • Apellis Pharmaceuticals' Debt Ratio rose 7.89% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 7.89%. This contributed to the annual value of 0.41 for FY2024, which is N/A change from last year.
  • Per Apellis Pharmaceuticals' latest filing, its Debt Ratio stood at 0.43 for Q3 2025, which was down 2.16% from 0.44 recorded in Q2 2025.
  • Over the past 5 years, Apellis Pharmaceuticals' Debt Ratio peaked at 0.45 during Q1 2025, and registered a low of 0.40 during Q3 2024.
  • For the 2-year period, Apellis Pharmaceuticals' Debt Ratio averaged around 0.42, with its median value being 0.42 (2024).
  • Data for Apellis Pharmaceuticals' Debt Ratio shows a peak YoY climbed of 9.06% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Apellis Pharmaceuticals' Debt Ratio stood at 0.41 in 2024, then grew by 7.89% to 0.43 in 2025.
  • Its Debt Ratio stands at 0.43 for Q3 2025, versus 0.44 for Q2 2025 and 0.45 for Q1 2025.